208 related articles for article (PubMed ID: 18571586)
21. Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis.
van Veen SQ; Levi M; van Vliet AK; Florquin S; van Gulik TM; Boermeester MA
Crit Care Med; 2006 Nov; 34(11):2799-805. PubMed ID: 17006359
[TBL] [Abstract][Full Text] [Related]
22. The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: indications for the use of urokinase in peritoneal dialysis-associated peritonitis.
Caring for Australians with Renal Impairment (CARI)
Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S56-8. PubMed ID: 15469559
[No Abstract] [Full Text] [Related]
23. [Usefulness of urokinase in intraabdominal abscesses].
García Pérez I; González Vega A
Cir Esp; 2010 Jul; 88(1):53-4. PubMed ID: 19783244
[No Abstract] [Full Text] [Related]
24. Adenovirus-mediated overexpression of human tissue plasminogen activator prevents peritoneal adhesion formation/reformation in rats.
Atta HM; Al-Hendy A; El-Rehany MA; Dewerchin M; Abdel Raheim SR; Abdel Ghany H; Fouad R
Surgery; 2009 Jul; 146(1):12-7. PubMed ID: 19541005
[TBL] [Abstract][Full Text] [Related]
25. Local treatment of generalised peritonitis in rats; effects on bacteria, endotoxin and mortality.
Rosman C; Westerveld GJ; Kooi K; Bleichrodt RP
Eur J Surg; 1999 Nov; 165(11):1072-9. PubMed ID: 10595613
[TBL] [Abstract][Full Text] [Related]
26. The effect of polysaccharides and carboxymethylcellulose combination to prevent intraperitoneal adhesion and abscess formation in a rat peritonitis model.
Bae JS; Jin HK; Jang KH
J Vet Med Sci; 2004 Oct; 66(10):1205-11. PubMed ID: 15528850
[TBL] [Abstract][Full Text] [Related]
27. Tissue plasminogen activator as an adjuvant therapy for pleural empyema in pediatric patients.
Ray TL; Berkenbosch JW; Russo P; Tobias JD
J Intensive Care Med; 2004; 19(1):44-50. PubMed ID: 15035754
[TBL] [Abstract][Full Text] [Related]
28. Characterization of cerebral tissue by MRI map ISODATA in embolic stroke in rat.
Ding G; Jiang Q; Li L; Zhang L; Zhang ZG; Soltanian-Zadeh H; Li Q; Whitton PA; Ewing JR; Chopp M
Brain Res; 2006 Apr; 1084(1):202-9. PubMed ID: 16566903
[TBL] [Abstract][Full Text] [Related]
29. [Principles of therapy with fibrinolytic agents].
Hiller E
Fortschr Med; 1986 Aug; 104(30):571-4. PubMed ID: 3093343
[No Abstract] [Full Text] [Related]
30. Intraperitoneal octenidindihydro-chloride - phenoxyethanol solution to prevent peritoneal adhesion formation in a rat peritonitis model.
Güzelsağaltici N; Girgin S; Gedik E; Büyükbayram H; Baç B
Acta Obstet Gynecol Scand; 2007; 86(4):395-400. PubMed ID: 17486458
[TBL] [Abstract][Full Text] [Related]
31. The role of tissue plasminogen activator in the management of complex intra-abdominal abscesses in children.
Shawyer AC; Amaral JG; Langer JC
J Pediatr Surg; 2012 Jul; 47(7):1380-4. PubMed ID: 22813800
[TBL] [Abstract][Full Text] [Related]
32. Early procoagulant shift in the bronchoalveolar compartment of patients with secondary peritonitis.
van Till JW; Levi M; Bresser P; Schultz MJ; Gouma DJ; Boermeester MA
J Infect Dis; 2006 Nov; 194(9):1331-9. PubMed ID: 17041861
[TBL] [Abstract][Full Text] [Related]
33. Prevention of intraperitoneal adhesion formation using beta-glucan after ileocolic anastomosis in a rat bacterial peritonitis model.
Bedirli A; Gokahmetoglu S; Sakrak O; Ersoz N; Ayangil D; Esin H
Am J Surg; 2003 Apr; 185(4):339-43. PubMed ID: 12657386
[TBL] [Abstract][Full Text] [Related]
34. An evaluation of normal saline and taurolidine on intra-abdominal adhesion formation and peritoneal fibrinolysis.
Tarhan OR; Barut I; Sezik M
J Surg Res; 2008 Jan; 144(1):151-7. PubMed ID: 17981298
[TBL] [Abstract][Full Text] [Related]
35. Reduced neutrophil sequestration in lung tissue after laparoscopic lavage in a rat peritonitis model.
Pross M; Mantke R; Kunz D; Reinheckel T; Halangk W; Lippert H; Schulz HU
World J Surg; 2002 Jan; 26(1):49-53. PubMed ID: 11898033
[TBL] [Abstract][Full Text] [Related]
36. A standardised and reproducible model of intraabdominal infection and abscess formation in rats.
Bosscha K; Nieuwenhuijs VB; Gooszen AW; van Duijvenbode-Beumer H; Visser MR; Verweij WR; Akkermans LM
Eur J Surg; 2000 Dec; 166(12):963-7. PubMed ID: 11152259
[TBL] [Abstract][Full Text] [Related]
37. [Can dexpanthenol prevent peritoneal adhesion formation? An experimental study].
Akdeniz Y; Tarhan OR; Barut I
Ulus Travma Acil Cerrahi Derg; 2007 Apr; 13(2):94-100. PubMed ID: 17682950
[TBL] [Abstract][Full Text] [Related]
38. The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.
Cook AD; Vlahos R; Massa CM; Braine EL; Lenzo JC; Turner AL; Way KJ; Hamilton JA
Thromb Haemost; 2006 Apr; 95(4):659-67. PubMed ID: 16601837
[TBL] [Abstract][Full Text] [Related]
39. Lung endothelium targeting for pulmonary embolism thrombolysis.
Ding BS; Zhou YJ; Chen XY; Zhang J; Zhang PX; Sun ZY; Tan XY; Liu JN
Circulation; 2003 Dec; 108(23):2892-8. PubMed ID: 14610017
[TBL] [Abstract][Full Text] [Related]
40. Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits.
Idell S; Azghani A; Chen S; Koenig K; Mazar A; Kodandapani L; Bdeir K; Cines D; Kulikovskaya I; Allen T
Exp Lung Res; 2007; 33(8-9):419-40. PubMed ID: 17994370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
